TNF and Insulin resistance: Anti-TNF treatment reduced DAS28 (P = 0.007), HAQ (P = 0.002), and CRP (P = 0.002) in patients with insulin resistance but not in those with HOMA-IR ≤ 2.0 (data not shown).